SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: PawPr who wrote (628)4/3/1998 8:42:00 PM
From: FNS  Respond to of 965
 
RE: <<I think Avakine goes before the FDA late in May.>>
Thanks, Bruce. In regards to Merk's Accustat (?), CNTO can be expected to take another hit around April 10th ... come May, assuming advisory approval in May (?), CNTO should get a bounce. Quite likely that CNTO may announce a partner at this time or shortly after.

This all means that current QTR earnings goes by w/o partner dollars; but, hopefully, the next QTR should include.

FNS


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News